Pace Logo

Life Sciences

Pace Life Sciences San German Laboratory

Pace® Life Sciences’ San German Site Receives Positive Inspection from FDA

Company commitment to quality excellence confirmed during FDA Inspection MINNEAPOLIS, MN – August 21, 2025– Pace® Life Sciences, a U.S.-based contract, research, development and manufacturing organization (CRDMO) and full-service FDA-registered GMP Analytical Testing laboratory announced today that its San German, Puerto Rico site has received a positive FDA Inspection of its quality systems and client data […]

Pace® Life Sciences’ San German Site Receives Positive Inspection from FDA Read More »

Pace® Life Sciences has been recognized by PharmaSource as a Top CDMO in the United States

The United States is global powerhouse in pharmaceutical contract development and manufacturing, home to some of the world’s most advanced CDMOs. The U.S. combines scale, scientific leadership, and advanced regulatory infrastructure to support drug development from early-stage innovation to commercial manufacturing. The U.S. currently leads biomedical research globally, conducting roughly 46% of all life‑sciences R&D. The contract manufacturing

Pace® Life Sciences has been recognized by PharmaSource as a Top CDMO in the United States Read More »

Ribbon cutting at Pace Life Sciences Laboratory Expansion in Salem, MA.

Pace® Life Sciences Debuts Enhanced cGMP Manufacturing Capabilities to Support Increasing Demand for Sterile Injectables

Company reopens state-of-the-art isolated vial filling line at Aseptic Fill-Finish Center of Excellence MINNEAPOLIS, MN – August 12, 2025 – Pace® Life Sciences, a U.S.-based contract, research, development and manufacturing organization (CRDMO) and full-service FDA-registered GMP Analytical Testing laboratory re-opened its 33,000 square foot facility in Salem, NH with advanced technologies to support small batch manufacturing.

Pace® Life Sciences Debuts Enhanced cGMP Manufacturing Capabilities to Support Increasing Demand for Sterile Injectables Read More »

Pace Life Sciences Scientist working in laboratory.

Pace® Life Sciences Achieves Fourth Consecutive Positive FDA Inspection, Reinforcing Quality Commitment

Research Triangle Park, NC site received a positive FDA Review, marking a milestone as all company Analytical Outsourcing sites have achieved successful recent inspections  MINNEAPOLIS, MN – July 29, 2025 – Pace® Life Sciences, a U.S.-based full-service FDA-registered GMP Analytical Testing laboratory and contract, research, development and manufacturing organization (CRDMO) and a Division of Pace®, a

Pace® Life Sciences Achieves Fourth Consecutive Positive FDA Inspection, Reinforcing Quality Commitment Read More »

Rendering of Life Sciences Aseptic Fil-Finish expansion

Pace® Life Sciences Hosts Grand Opening of its Center of Excellence for Aseptic Fill-Finish Services in Salem, NH

July 16 open house highlights expanded sterile filling contract manufacturing capabilities for small and large molecules Minneapolis, MN – July 2, 2025 – Pace® Life Sciences, LLC, a U.S.-based contract research, development, and manufacturing organization (CRDMO) and a Division of Pace®, a Science and Technology Company, builds upon its growth in the pharma and biotech

Pace® Life Sciences Hosts Grand Opening of its Center of Excellence for Aseptic Fill-Finish Services in Salem, NH Read More »

Pace Life Sciences Lebanon NJ location. Pace Scientist working in Laboratory

Pace® Life Sciences Announces Successful Pre-Approval Inspection from US FDA in Lebanon, NJ

Company confirms high standards for data integrity and quality systems  MINNEAPOLIS, MN, May 20, 2025 Pace® Life Sciences, a U.S.-based full-service FDA-registered GMP Analytical Testing laboratory and contract, research, development and manufacturing organization (CRDMO) and a Division of Pace®, a Science and Technology Company, announced today a successful Pre-Approval Inspection (PAI) from The Food & Drug

Pace® Life Sciences Announces Successful Pre-Approval Inspection from US FDA in Lebanon, NJ Read More »

Dean Bornilla, Pace Life Sciences.

Future role of Pace® Life Sciences in supporting biopharmaceutical development and manufacturing coast-to-coast – Dean Bornilla, Vice President.

With a growing network of locations across major US pharmaceutical hubs, Pace® aims to enhance customer experience through consistent quality and timely delivery.  Pace® Life Sciences, a biopharmaceutical services provider, has experienced significant growth through recent acquisitions of analytical labs, substantially increasing their testing capacity and scientific expertise. Looking ahead to 2025, Pace® is undertaking

Future role of Pace® Life Sciences in supporting biopharmaceutical development and manufacturing coast-to-coast – Dean Bornilla, Vice President. Read More »

Pace Life Sciences Awarded Bronze Medal from EcoVadis for Commitment to Sustainability

Pace® Life Sciences Awarded Bronze Medal from EcoVadis for Commitment to Sustainability

Company stands out in Ethics, Environment, and Labor and Human Rights focus areas for 2024  Minneapolis, MN – April 1, 2025 –Pace® Life Sciences, LLC, a U.S.-based contract research, development, and manufacturing organization (CRDMO) and a Division of Pace®, a Science and Technology Company, is pleased to announce that it has received a Bronze Medal award

Pace® Life Sciences Awarded Bronze Medal from EcoVadis for Commitment to Sustainability Read More »

Frank Tagliaferri, Pace Life Sciences

Addressing the Complexity of Modern Therapeutics – Dr. Frank Tagliaferri, Pace® Life Sciences

The modern therapeutic landscape is defined by an ever-growing portfolio of complex drug products – from biologics and gene therapies to mRNA-based vaccines and monoclonal antibodies. These therapies, which often involve intricate fomulations and require advanced sterile processing, have fundamentally altered the demands placed on fill-finish operations. Frank Tagliaferri, chief scientific officer at Pace® Life

Addressing the Complexity of Modern Therapeutics – Dr. Frank Tagliaferri, Pace® Life Sciences Read More »

Pace Life Sciences Scientist working in laboratory.

Pace® Life Sciences to Expand Large Molecule Development, Manufacturing, and Analytical Testing Capacity in 2025

Company expands sterile fill-finish services, capacity for biologics development and manufacturing, and more. Minneapolis, MN – January 10, 2025 – Pace® Life Sciences, LLC, a U.S.-based contract research, development, and manufacturing organization (CRDMO) and a Division of Pace®, a Science and Technology Company, today announced significant growth plans for two of the company’s locations. Pace® Life

Pace® Life Sciences to Expand Large Molecule Development, Manufacturing, and Analytical Testing Capacity in 2025 Read More »